Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
AssigneesTeva Pharmaceutical Industries Ltd., Technion Research & Development Foundation Limited
InventorsSasson Cohen, Yaacov Herzig, Ruth Levy, Jeff Sterling, Alex Veinberg, Moussa B. H. Youdim, John P. M. Finberg
Life of this patent
Estimating the term…
Abstract
Novel derivatives of 1-aminoindan and their salts are described. Optically active 1-aminoindan derivatives are prepared by reacting a N-benzyl analog of the desired compound with an enantiomer of mandelic acid. Parkinson's disease, dementia, epilepsy, convulsions, or seizures are treated by administering a compound of the formula: ##STR1##
Claims29
A method for treating dementia in a subject comprising administering to the subject a therapeutically effective amount of a compound of the formula:
- ##STR12## or a pharmaceutically acceptable salt thereof;
- wherein
- n is 0 or 1;
- R.sub.1 and R.sub.2 are each independently hydrogen, substituted or unsubstituted C.sub.1 -C.sub.4 alkyl, halogen, nitro, --NH--R.sub.11, --C(O)--R.sub.11 or --C(O)--NR.sub.9 R.sub.10, wherein
- R.sub.11 is hydrogen, substituted or unsubstituted C.sub.1 C.sub.4 alkyl, hydroxy, substituted or unsubstituted C.sub.1 -C.sub.4 alkoxy, and
- R.sub.9 and R.sub.10 are each independently hydrogen, C.sub.1 -C.sub.12 alkyl, substituted or unsubstituted C.sub.6 -C.sub.12 aryl, substituted or unsubstituted C.sub.7 -C.sub.12 aralkyl, or indanyl;
- R.sub.3 is hydrogen, substituted or unsubstituted C.sub.1 -C.sub.4 alkyl, hydroxy, substituted or unsubstituted C.sub.1 -C.sub.4 alkoxy;
- R.sub.4 is hydrogen, substituted or unsubstituted C.sub.1 -C.sub.12 alkyl, substituted or unsubstituted C.sub.6 -C.sub.12 aryl, substituted or unsubstituted C.sub.7 -C.sub.12 aralkyl, or --C(O)--R.sub.6,
- wherein R.sub.6 is hydrogen, C.sub.1 -C.sub.12 alkly, substituted or unsubstituted C.sub.6 -C.sub.12 aryl, substituted or unsubstituted C.sub.7 -C.sub.12 aralkyl;
- R.sub.5 is hydrogen, C.sub.1 -C.sub.12 alkyl, substituted or unsubstituted C.sub.6 -C.sub.12 aryl, substituted or unsubstituted C.sub.7 -C.sub.12 aralkyl, or A--NR.sub.9 R.sub.10, --Y--C(O)--R.sub.7 or --Y--(SO2)NR.sub.9 R.sub.10,
- wherein A is substituted or unsubstituted C.sub.6 -C.sub.12 aryl, substituted or unsubstituted C.sub.7 -C.sub.12 aralkyl, and
- R.sub.9 and R.sub.10 are each independently hydrogen, substituted C.sub.1 -C.sub.12 alkyl, substituted or unsubstituted C.sub.6 -C.sub.12 aryl, substituted or unsubstituted C.sub.7 -C.sub.12 aralkyl, or indanyl;
- Y is substituted or unsubstituted C.sub.6 -C.sub.12 aryl, substituted or unsubstituted C.sub.7 -C.sub.12 aralkyl, and
- R.sub.7 is hydrogen, hydroxy, substituted or unsubstituted C.sub.6 -C.sub.12 aryl, substituted or unsubstituted C.sub.7 -C.sub.12 aralkyl.
The method according to claim wherein the dementia is senile dementia.
Dependencies are inferred from the claim text.